Healthcare Tracked since Q3 FY26 - Q3 FY26

Lincoln Pharmaceuticals Ltd

Compare with...

LINCOLNPHARMACEUTICALS

Latest quarter Q3 FY26

Revenue ₹166 Cr (+13.5% YoY)

Management credibility Building

Promise tracking available after 2+ quarters of coverage.

View all executive profiles for Lincoln Pharmaceuticals Ltd

Latest signal bullish medium

Lincoln Pharma delivered a solid Q3 FY26 with revenue of ₹166.3 Cr (+13.5% YoY) and PAT of ₹28.6 Cr (+37.7% YoY), dri...

Quarterly Earnings Timeline

Financial verification status, call summary, sentiment, and management-delivery signals by quarter.

1 quarter

Q3 FY26 15 Feb 2026

Revenue ₹166 Cr (+13.5% YoY)

Lincoln Pharma delivered a solid Q3 FY26 with revenue of ₹166.3 Cr (+13.5% YoY) and PAT of ₹28.6 Cr (+37.7% YoY), driven by strong export growth and the new cephalospo...

bullish medium

Scorecard starts after historical backfill Read full analysis →